Please provide your email address to receive an email when new articles are posted on . “The cell-free DNA is the first blood-based test with performance that is comparable to current guideline ...
A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in most people confirmed to have the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “More than three out of four Americans who die from ...
The US Food and Drug Administration (FDA) approved Exact Sciences' next-generation multitarget stool DNA (mt-sDNA) test, Cologuard Plus, for use in adults 45 or older who are at average risk for ...
Cologuard® CRC Screening Test Most Cost-Effective Test in Medically Underserved Alaska Native People
MADISON, Wis., April 28, 2021 /PRNewswire/ -- Exact Sciences (NASDAQ: EXAS) today announces study results published in Mayo Clinic Proceedings showing that Cologuard (mt-sDNA) is the most ...
In a comparison against multiple alternative screening strategies, a cell-free DNA blood test (cf-bDNA) prevented the fewest cancers and cancer-specific deaths versus no screening. With an estimated ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Freenome, a privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection with a routine blood ...
The FirstSightCRC blood-based multimodal colorectal cancer test could be inching its way closer to market, OncLive reports. 1. Shai Friedland, MD, of Stanford (Calif.) Health Care, presented interim ...
Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps Results of multi-institutional clinical study published in peer reviewed journal ‘Cancers’ confirms efficacy ...
The new guideline, similar to the previous version, recommends screening for CRC for those 50 to 75 years of age and leaves the decision for screening in those 76 to 85 years of age on the individual.
MedTech Outlook named Epi proColon test creator Epigenomics AG one of its 2019 Top 10 In-Vitro Diagnostic Award winners. What you should know: 1. MedTech Outlook created the award to recognize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback